Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.391
-0.023 (-5.58%)
At close: Mar 5, 2026, 4:00 PM EST
0.391
-0.000 (-0.08%)
Pre-market: Mar 6, 2026, 7:09 AM EST
Mereo BioPharma Group Stock Forecast
MREO's stock price has decreased by -84.3% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Mereo BioPharma Group stock have an average target of 3.90, with a low estimate of 0.50 and a high estimate of 8.00. The average target predicts an increase of 897.44% from the current stock price of 0.39.
Analyst Consensus: Buy
* Price targets were last updated on Jan 16, 2026.
Analyst Ratings
The average analyst rating for Mereo BioPharma Group stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $1 | Strong Buy | Reiterates | $1 | +155.75% | Jan 16, 2026 |
| Needham | Needham | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +667.26% | Jan 13, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $7 → $0.5 | Strong Buy → Hold | Downgrades | $7 → $0.5 | +27.88% | Dec 30, 2025 |
| BTIG | BTIG | Strong Buy Maintains $6 → $1 | Strong Buy | Maintains | $6 → $1 | +155.75% | Dec 29, 2025 |
| LifeSci Capital | LifeSci Capital | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 29, 2025 |
Financial Forecast
Revenue This Year
530.40K
Revenue Next Year
34.28M
from 530.40K
Increased by 6,363.05%
EPS This Year
-0.06
from -0.29
EPS Next Year
-0.03
from -0.06
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 840,000 | 71.9M | ||||
| Avg | 530,400 | 34.3M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 13,449.0% | ||||
| Avg | - | 6,363.0% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.06 | 0.04 | ||||
| Avg | -0.06 | -0.03 | ||||
| Low | -0.06 | -0.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.